Do patients with cervical spondylosis (degenerative disc disease in the neck) with radiculopathy (nerve root damage) and bone spurs warrant HLA (Human Leukocyte Antigen) B27 testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HLA-B27 Testing is NOT Warranted for Cervical Spondylosis with Radiculopathy and Bone Spurs

HLA-B27 testing should not be ordered for patients presenting with cervical spondylosis, radiculopathy, and bone spurs, as these findings represent typical degenerative disease rather than inflammatory spondyloarthropathy.

Clinical Distinction Between Degenerative and Inflammatory Disease

The clinical presentation described—cervical spondylosis with radiculopathy and bone spurs—represents classic degenerative disc disease, not inflammatory spondyloarthropathy:

  • Cervical spondylosis with radiculopathy results from mechanical nerve root compression caused by herniated disc material, calcified discs, or osteophytes (bone spurs), which are degenerative changes typical in middle-aged and elderly patients 1, 2

  • Bone spurs (osteophytes) are hallmarks of degenerative disease, not the syndesmophytes or bamboo spine characteristic of ankylosing spondylitis where HLA-B27 would be relevant 3

  • Radiculopathy from cervical spondylosis presents with neck pain radiating to the arm with sensory or motor deficits in a dermatomal distribution, which is mechanically mediated compression rather than inflammatory pathology 4, 2, 5

When HLA-B27 Testing Would Be Appropriate

HLA-B27 testing is indicated for suspected inflammatory spondyloarthropathies (ankylosing spondylitis, reactive arthritis, psoriatic arthritis), which present with distinctly different clinical features:

  • Inflammatory back pain (insidious onset, age <40 years, morning stiffness >30 minutes, improvement with exercise, nocturnal pain in second half of night)
  • Sacroiliitis on imaging
  • Syndesmophytes (vertical bony bridges) rather than degenerative osteophytes
  • Systemic inflammatory features (uveitis, inflammatory bowel disease, psoriasis, enthesitis)

Clinical Management Focus

For cervical spondylosis with radiculopathy and bone spurs, the appropriate diagnostic and therapeutic approach includes:

  • MRI of the cervical spine without contrast to confirm nerve root compression and evaluate soft tissue pathology 4

  • Conservative management as first-line therapy, since 75-90% of cervical radiculopathy patients achieve symptomatic relief with nonoperative treatment including activity modification, physical therapy, NSAIDs, and cervical immobilization 4, 2

  • Surgical consultation (posterior laminoforaminotomy or anterior approaches) only for progressive neurologic deficits, severe refractory pain, or myelopathy 1

Common Pitfall to Avoid

Do not confuse degenerative osteophytes with inflammatory syndesmophytes. The presence of bone spurs in cervical spondylosis represents wear-and-tear changes from disc degeneration, not the inflammatory new bone formation seen in HLA-B27-associated spondyloarthropathies 3. Ordering HLA-B27 in this degenerative context wastes resources and may lead to diagnostic confusion, as HLA-B27 is present in 6-8% of the general Caucasian population without disease.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cervical spondylosis. An update.

The Western journal of medicine, 1996

Guideline

Management of Cervical Radiculopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.